Mora, S., Wenger, N. K., DeMicco, D. A., Breazna, A., Boekholdt, S. M., Arsenault, B. J., . . . Waters, D. D. (2012). Determinants of Residual Risk in Secondary Prevention Patients Treated with High-Versus Low-Dose Statin Therapy: The Treating to New Targets (TNT) Study.

Mora, Samia, Nanette K. Wenger, David A. DeMicco, Andrei Breazna, S. Matthijs Boekholdt, Benoit J. Arsenault, Prakash Deedwania, John J.P Kastelein, ja David D. Waters. Determinants of Residual Risk in Secondary Prevention Patients Treated With High-Versus Low-Dose Statin Therapy: The Treating to New Targets (TNT) Study. 2012.

Mora, Samia, et al. Determinants of Residual Risk in Secondary Prevention Patients Treated With High-Versus Low-Dose Statin Therapy: The Treating to New Targets (TNT) Study. 2012.